(ASML) ASML Holding - Overview
Exchange: NASDAQ •
Country: Netherlands •
Currency: USD •
Type: Common Stock •
ISIN: USN070592100
Stock: Lithography, Metrology, Inspection, Upgrade, Service
Total Rating 72
Risk 97
Buy Signal 0.81
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.95% |
| Yield on Cost 5y | 2.25% |
| Yield CAGR 5y | 16.85% |
| Payout Consistency | 84.9% |
| Payout Ratio | 29.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 43.4% |
| Relative Tail Risk | -6.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.70 |
| Alpha | 71.18 |
| Character TTM | |
|---|---|
| Beta | 1.457 |
| Beta Downside | 1.238 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.48% |
| CAGR/Max DD | 0.67 |
Description: ASML ASML Holding February 05, 2026
ASML Holding N.V. designs, manufactures, and services advanced lithography equipment that enables semiconductor manufacturers to print circuit patterns onto wafers. Its portfolio spans extreme-ultraviolet (EUV) systems, deep-ultraviolet (DUV) immersion and dry tools, metrology and inspection solutions (e.g., YieldStar optical metrology, HMI electron-beam defect analysis), and computational lithography software, together with refurbishment, upgrades, and customer support worldwide.
Key recent metrics (Q2 2024): Revenue reached €7.0 billion, up 14 % YoY, driven by a 22 % increase in EUV system shipments (27 units) and a record order backlog of €40 billion, reflecting strong demand from AI-focused fab expansions in the United States and Taiwan. R&D intensity remains high at ~15 % of revenue, supporting a 45 % market-share lead in EUV lithography. Macro-level drivers include the global push for advanced nodes (5 nm and below) and government incentives for domestic chip production, which together sustain ASML’s pricing power but expose the company to cyclical fab-capacity utilization risks.
For a deeper, data-driven look at ASML’s valuation and risk profile, see the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 9.23b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 1.63 > 1.0 |
| NWC/Revenue: 20.24% < 20% (prev 37.81%; Δ -17.57% < -1%) |
| CFO/TA 0.25 > 3% & CFO 12.86b > Net Income 9.23b |
| Net Debt (-10.20b) to EBITDA (12.09b): -0.84 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (388.9m) vs 12m ago -1.19% < -2% |
| Gross Margin: 52.83% > 18% (prev 0.51%; Δ 5232 % > 0.5%) |
| Asset Turnover: 63.30% > 50% (prev 58.17%; Δ 5.14% > 0%) |
| Interest Coverage Ratio: -186.3 > 6 (EBITDA TTM 12.09b / Interest Expense TTM -59.6m) |
Beneish M -3.27
| DSRI: 0.69 (Receivables 4.16b/5.44b, Revenue 31.38b/28.26b) |
| GMI: 0.97 (GM 52.83% / 51.28%) |
| AQI: 1.06 (AQ_t 0.23 / AQ_t-1 0.22) |
| SGI: 1.11 (Revenue 31.38b / 28.26b) |
| TATA: -0.07 (NI 9.23b - CFO 12.86b) / TA 50.55b) |
| Beneish M-Score: -3.27 (Cap -4..+1) = AA |
What is the price of ASML shares?
As of February 08, 2026, the stock is trading at USD 1413.01 with a total of 1,891,604 shares traded.
Over the past week, the price has changed by -0.70%, over one month by +13.75%, over three months by +37.29% and over the past year by +93.00%.
Over the past week, the price has changed by -0.70%, over one month by +13.75%, over three months by +37.29% and over the past year by +93.00%.
Is ASML a buy, sell or hold?
ASML Holding has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy ASML.
- StrongBuy: 22
- Buy: 8
- Hold: 9
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the ASML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1483.6 | 5% |
| Analysts Target Price | 1483.6 | 5% |
| ValueRay Target Price | 1855.9 | 31.3% |
ASML Fundamental Data Overview February 07, 2026
Market Cap EUR = 443.88b (524.06b USD * 0.847 USD.EUR)
P/E Trailing = 46.3018
P/E Forward = 40.3226
P/S = 16.0424
P/B = 22.6167
P/EG = 2.2864
Revenue TTM = 31.38b EUR
EBIT TTM = 11.10b EUR
EBITDA TTM = 12.09b EUR
Long Term Debt = 2.71b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.20b EUR (from netDebt column, last quarter)
Enterprise Value = 433.27b EUR (443.88b + Debt 2.71b - CCE 13.32b)
Interest Coverage Ratio = -186.3 (Ebit TTM 11.10b / Interest Expense TTM -59.6m)
EV/FCF = 40.38x (Enterprise Value 433.27b / FCF TTM 10.73b)
FCF Yield = 2.48% (FCF TTM 10.73b / Enterprise Value 433.27b)
FCF Margin = 34.20% (FCF TTM 10.73b / Revenue TTM 31.38b)
Net Margin = 29.42% (Net Income TTM 9.23b / Revenue TTM 31.38b)
Gross Margin = 52.83% ((Revenue TTM 31.38b - Cost of Revenue TTM 14.80b) / Revenue TTM)
Gross Margin QoQ = 53.07% (prev 51.63%)
Tobins Q-Ratio = 8.57 (Enterprise Value 433.27b / Total Assets 50.55b)
Interest Expense / Debt = 0.47% (Interest Expense 12.7m / Debt 2.71b)
Taxrate = 17.87% (451.3m / 2.53b)
NOPAT = 9.12b (EBIT 11.10b * (1 - 17.87%))
Current Ratio = 1.26 (Total Current Assets 30.60b / Total Current Liabilities 24.25b)
Debt / Equity = 0.14 (Debt 2.71b / totalStockholderEquity, last quarter 19.60b)
Debt / EBITDA = -0.84 (Net Debt -10.20b / EBITDA 12.09b)
Debt / FCF = -0.95 (Net Debt -10.20b / FCF TTM 10.73b)
Total Stockholder Equity = 18.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.62% (Net Income 9.23b / Total Assets 50.55b)
RoE = 50.08% (Net Income TTM 9.23b / Total Stockholder Equity 18.43b)
RoCE = 52.53% (EBIT 11.10b / Capital Employed (Equity 18.43b + L.T.Debt 2.71b))
RoIC = 285.1% (NOPAT 9.12b / Invested Capital 3.20b)
WACC = 11.21% (E(443.88b)/V(446.59b) * Re(11.28%) + D(2.71b)/V(446.59b) * Rd(0.47%) * (1-Tc(0.18)))
Discount Rate = 11.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.62%
[DCF Debug] Terminal Value 61.09% ; FCFF base≈10.25b ; Y1≈7.78b ; Y5≈4.74b
Fair Price DCF = 171.6 (EV 56.42b - Net Debt -10.20b = Equity 66.62b / Shares 388.1m; r=11.21% [WACC]; 5y FCF grow -28.62% → 2.90% )
EPS Correlation: 64.40 | EPS CAGR: 42.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: 74.52 | Revenue CAGR: 26.08% | SUE: -1.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=6.65 | Chg30d=+1.114 | Revisions Net=+6 | Analysts=14
EPS current Year (2026-12-31): EPS=29.33 | Chg30d=+3.164 | Revisions Net=+24 | Growth EPS=+18.7% | Growth Revenue=+13.2%
EPS next Year (2027-12-31): EPS=36.71 | Chg30d=+4.478 | Revisions Net=+23 | Growth EPS=+25.2% | Growth Revenue=+17.2%
P/E Trailing = 46.3018
P/E Forward = 40.3226
P/S = 16.0424
P/B = 22.6167
P/EG = 2.2864
Revenue TTM = 31.38b EUR
EBIT TTM = 11.10b EUR
EBITDA TTM = 12.09b EUR
Long Term Debt = 2.71b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.20b EUR (from netDebt column, last quarter)
Enterprise Value = 433.27b EUR (443.88b + Debt 2.71b - CCE 13.32b)
Interest Coverage Ratio = -186.3 (Ebit TTM 11.10b / Interest Expense TTM -59.6m)
EV/FCF = 40.38x (Enterprise Value 433.27b / FCF TTM 10.73b)
FCF Yield = 2.48% (FCF TTM 10.73b / Enterprise Value 433.27b)
FCF Margin = 34.20% (FCF TTM 10.73b / Revenue TTM 31.38b)
Net Margin = 29.42% (Net Income TTM 9.23b / Revenue TTM 31.38b)
Gross Margin = 52.83% ((Revenue TTM 31.38b - Cost of Revenue TTM 14.80b) / Revenue TTM)
Gross Margin QoQ = 53.07% (prev 51.63%)
Tobins Q-Ratio = 8.57 (Enterprise Value 433.27b / Total Assets 50.55b)
Interest Expense / Debt = 0.47% (Interest Expense 12.7m / Debt 2.71b)
Taxrate = 17.87% (451.3m / 2.53b)
NOPAT = 9.12b (EBIT 11.10b * (1 - 17.87%))
Current Ratio = 1.26 (Total Current Assets 30.60b / Total Current Liabilities 24.25b)
Debt / Equity = 0.14 (Debt 2.71b / totalStockholderEquity, last quarter 19.60b)
Debt / EBITDA = -0.84 (Net Debt -10.20b / EBITDA 12.09b)
Debt / FCF = -0.95 (Net Debt -10.20b / FCF TTM 10.73b)
Total Stockholder Equity = 18.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.62% (Net Income 9.23b / Total Assets 50.55b)
RoE = 50.08% (Net Income TTM 9.23b / Total Stockholder Equity 18.43b)
RoCE = 52.53% (EBIT 11.10b / Capital Employed (Equity 18.43b + L.T.Debt 2.71b))
RoIC = 285.1% (NOPAT 9.12b / Invested Capital 3.20b)
WACC = 11.21% (E(443.88b)/V(446.59b) * Re(11.28%) + D(2.71b)/V(446.59b) * Rd(0.47%) * (1-Tc(0.18)))
Discount Rate = 11.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.62%
[DCF Debug] Terminal Value 61.09% ; FCFF base≈10.25b ; Y1≈7.78b ; Y5≈4.74b
Fair Price DCF = 171.6 (EV 56.42b - Net Debt -10.20b = Equity 66.62b / Shares 388.1m; r=11.21% [WACC]; 5y FCF grow -28.62% → 2.90% )
EPS Correlation: 64.40 | EPS CAGR: 42.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: 74.52 | Revenue CAGR: 26.08% | SUE: -1.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=6.65 | Chg30d=+1.114 | Revisions Net=+6 | Analysts=14
EPS current Year (2026-12-31): EPS=29.33 | Chg30d=+3.164 | Revisions Net=+24 | Growth EPS=+18.7% | Growth Revenue=+13.2%
EPS next Year (2027-12-31): EPS=36.71 | Chg30d=+4.478 | Revisions Net=+23 | Growth EPS=+25.2% | Growth Revenue=+17.2%